Andrew Guggenhime's Net Worth
Andrew Guggenhime's net worth is estimated to be at least $3,046,603.00 as of 09/22/2023. CoreStreet's estimation of Andrew Guggenhime's net worth is based on their sale of stock and current holding of stock.
Andrew Guggenhime is CFO at Vaxcyte Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,100 units of PCVX stock on 09/19/2022. Their biggest sale was on 09/19/2016 when they sold 15,000 units of Journey Medical Corporation Common Stock stock for $525,150.00. They typically trade 5 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $3,046,603.00
Most recent insider trade:
- Sept. 19, 2022
Andrew Guggenhime's Insider Trading History
| Vaxcyte Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 19, 2022 | CFO | 3,100 | $26.10 | Sell | $80,910.00 |
Aug. 29, 2022 | CFO | 17,653 | $28.00 | Sell | $494,284.00 |
Aug. 26, 2022 | CFO | 1,295 | $28.00 | Sell | $36,260.00 |
Aug. 18, 2022 | CFO | 3,100 | $25.26 | Sell | $78,306.00 |
July 18, 2022 | CFO | 3,100 | $24.53 | Sell | $76,043.00 |
May 18, 2022 | CFO | 3,100 | $24.44 | Sell | $75,764.00 |
April 18, 2022 | CFO | 3,100 | $24.05 | Sell | $74,555.00 |
Dec. 23, 2021 | CFO | 3,100 | $24.00 | Sell | $74,400.00 |
Nov. 18, 2021 | CFO | 3,100 | $24.53 | Sell | $76,043.00 |
| Journey Medical Corporation Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 9, 2016 | CFO | 4,100 | $35.02 | Sell | $143,582.00 |
Oct. 11, 2016 | CFO | 10,900 | $34.34 | Sell | $374,306.00 |
Sept. 19, 2016 | CFO | 15,000 | $35.01 | Sell | $525,150.00 |
Sept. 12, 2016 | CFO | 10,000 | $32.53 | Sell | $325,300.00 |
Aug. 11, 2016 | CFO | 10,000 | $31.02 | Sell | $310,200.00 |
July 11, 2016 | CFO | 10,000 | $30.15 | Sell | $301,500.00 |